elevidys gene therapy

News

Sarepta Will Resume Gene Therapy Shipments

Sarepta shares rebound after shipments of gene therapy Elevidys resume in US

By Bhanvi Satija and Siddhi Mahatole (Reuters) -Sarepta Therapeutics shares snapped a three-day losing streak on Tuesday, as analysts said resumption of U.S. shipments for its muscular gene therapy soothes immediate concerns about liquidity and the therapy's withdrawal from the market.

· 1d · on MSN

FDA Says Sarepta Can Resume Gene Therapy in Some Patients

· 20h · on MSN

Sarepta will resume gene therapy shipments after FDA review of recent patient death

48m

Sarepta soars after FDA says some patients can get Elevidys

Sarepta Therapeutics Inc. shares rose sharply early Tuesday after US regulators reversed course and recommended that patients who can walk be allowed to take its gene therapy Elevidys again.

Parents call on FDA for path forward after Duchenne's gene therapy pause | Morning in America

The Food and Drug Administration has paused distribution of the gene therapy Elevidys following the death of a third patient ...

3don MSN

Two boys died after a gene therapy. This family won’t give up hope.

The Revell family hoped a gene therapy could buy time for their sons, who have a rare and fatal disease. After two patients ...

1don MSN

Sarepta rises 2%; Barclays downgrades to underweight on liquidity and Elevidys concerns

Sarepta Therapeutics (NASDAQ:SRPT) shares dropped sharply premarket on Monday before paring losses as Barclays revised its ...

Fierce Biotech4d

'We will crack gene therapy': Elevidys fallout doesn't dent Roche's hopes for modality

Roche’s move came against a backdrop of wider industry retreat from gene therapy, with Pfizer pulling its FDA-approved ...

4don MSN

Sarepta fails to win EU backing for muscle disorder gene therapy

Sarepta Therapeutics suffered another major setback on Friday as Europe's drug regulator decided not to recommend the ...

Explore more

Food and Drug Administration

Duchenne muscular dystrophy

Some results have been hidden because they may be inaccessible to you

Show inaccessible results